Skip to content
DefDex

Federal award

ORTHO-CLINICAL DIAGNOSTICS, INC

W81K0216P0289

Contract

Obligated and Ceiling

Obligated (net)
$1,186,909.04
Ceiling (potential value, not spending)
$1,186,909.04
Current value
$1,186,909.04
Gross positive obligations
$1,869,373.65

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ORTHO-CLINICAL DIAGNOSTICS, INC · JG5JF2JQJ121
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
JOHNSON & JOHNSON HEALTHCARE · LKV3QN1ND7D1
Awarding agency
Department of War · sub-agency 2100 · office W81K02
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0216P0289
Award type code
B
Actions
17 · Sep 20, 2016 to Jan 18, 2022
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History17

Award actions
DateFYModAction typeObligationCompany in company totals
Jan 18, 2022FY2022P00016B−$127,021.00
—
Oct 21, 2020FY2021P00015C$373,874.73
—
Oct 19, 2020FY2021P00014B$0.00
—
Mar 31, 2020FY2020P00013G$0.00
—
Mar 31, 2020FY2020P00012B−$361,712.95
—
Mar 3, 2020FY2020P00011B−$80,058.22
—
Oct 7, 2019FY2020P00010C$373,874.73
—
Aug 21, 2019FY2019P00009G$0.00
—
Aug 14, 2019FY2019P00008M$0.00
—
Apr 30, 2019FY2019P00007B−$113,672.44
—
Oct 30, 2018FY2019P00006C$373,874.73
—
Sep 14, 2018FY2018P00005G$0.00
—
Nov 6, 2017FY2018P00004C$373,874.73
—
Apr 13, 2017FY2017P00003G$0.00
—
Nov 23, 2016FY2017P00002D$0.00
—
Nov 1, 2016FY2017P00001C$373,874.73
—
Sep 20, 2016FY20160—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.